U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06866769) titled 'Efficacy of Biomarkers and CEUS Versus CTA in AAA Follow-up Post-EVAR' on Jan. 24.
Brief Summary: This prospective observational study evaluates the efficacy of contrast-enhanced ultrasound and biomarker determination in the follow-up of patients with abdominal aortic aneurysm (AAA) treated with Endovascular Aneurysm Repair (EVAR). Currently, computed tomography angiography (CTA) is the standard for follow-up, although it has disadvantages such as radiation exposure and the use of iodinated contrasts. Contrast-enhanced ultrasound (CEUS), free of radiation and nephrotoxicity, and biomarkers could reduce the need for CTA minimizing t...